RCE 0.00% 46.0¢ recce pharmaceuticals ltd

Ann: Additional Positive Patient Cases - Special Access Scheme, page-22

  1. 30 Posts.
    lightbulb Created with Sketch. 80
    would have been good if they provided a bit more info on what infections were present in each of those wounds especially references to ESKAPE pathogens- Wounds like this have almost certainly been cultured and that info would be available upon request especially if they were prepared to provide photos as examples
    Case C- Gram +ve & Gram -ve is not that helpful as most bacteria usually fall into one of the two categories.
    Didn't even supply that level of detail for the D & E cases.
    Its a bit of a step to infer that a surface spray cured osteomyelitis (thats how it reads)
    what happened to case study A & B??

    Don't get me wrong, i have waaaaay toooo much $$$ in this and wish it every success but stop being vague/ half smart with the descriptions. It doesn't do the company credibility any good
    still concerned about this plasma residence time issue which is a significant consideration with respect to IV use and in particular SEPSIS

    On a positive note- activity and progress seems good atm.
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.0M
Open High Low Value Volume
46.0¢ 46.5¢ 46.0¢ $145.6K 316.3K

Buyers (Bids)

No. Vol. Price($)
2 82151 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 57606 2
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.